Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2.

Teri SchreinerMolly Wilson-MurphyJan Mendelt-TillemaMichael WaltzRachel CoddenLeslie BensonMark GormanManu GoyalLauren B KruppTim LotzeSoe MarJayne NessMary R RenselShelly RoalstadMoses RodriguezJohn RoseNikita ShuklaEmmanuelle WaubantYolanda WheelerT Charles CasperTanuja Chitinis

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)

B-cell-depleting treatment was associated with a higher risk of COVID-19, higher rates of hospitalization, and ICU admission, suggesting this therapy carries a higher risk of severe infection in POMS and related disorders.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
intensive care unit
emergency department
early onset
stem cells
mechanical ventilation
young adults
mesenchymal stem cells
smoking cessation
cell therapy